Clinical Trial Update: Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating concurrent helical tomotherapy with chemotherapy in patients with unresectable stage III non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Non-Small-Cell Lung Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN